Chemotherapy of metastatic colon cancer in France: A population-based study - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Digestive and Liver Disease Année : 2021

Chemotherapy of metastatic colon cancer in France: A population-based study

Résumé

Aims: to describe, using data from a cancer registry in a well-defined French population, the therapeutic strategies and survival of patients with metastatic colon cancer (mCC). Methods: all patients with synchronous mCC diagnosed within the 2005-2014 period recorded in the digestive cancers registry of Burgundy were included. Results: 1286 mCC patients were included (57% male), of which 34.5% did not receive any antitumor treatment. Both, advanced age (≥75 years) and the Charlson comorbidity score ≥2 were significantly associated with the absence of antitumor treatment. Among the patients treated with chemotherapy, 59 and 33% received at least two and three lines, respectively. Most patients treated with chemotherapy (68%) did not receive first-line targeted therapy. Of patients aged ≥75 years, 57% received no chemotherapy and 56% of treated patients had first-line treatment only. Conclusion: this population-based study shows that more than one-third of patients with mCC receive no chemotherapy and that only 59% of treated patients receive treatment beyond the first line. This study also highlights the fact that more than half of patients ≥75 years do not get any antitumor treatment. In patients <75 years, the proportion of patients receiving chemotherapy and/or undergoing curative intent surgery tended to increase over time.
Fichier principal
Vignette du fichier
Manuscript HAL.pdf (483.44 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03215018 , version 1 (03-05-2021)

Identifiants

Citer

Léo Mas, Jean-Baptiste Bachet, Valérie Jooste, Côme Lepage, Anne-Marie Bouvier. Chemotherapy of metastatic colon cancer in France: A population-based study. Digestive and Liver Disease, 2021, ⟨10.1016/j.dld.2021.03.019⟩. ⟨hal-03215018⟩
112 Consultations
144 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More